In the News

Task Force draft recommendation supports earlier diabetes screening

The draft recommendation calls for screening patients ages 35 to 70 years who are overweight or obese. It is open for public comment through Monday, April 12.

GLP-1 receptor agonists, thiazolidinediones associated with lower risk of ischemic stroke

A recent meta-analysis from Denmark looked at patients with genetic variations that cause increases in plasma glucose levels and found that their elevated ischemic stroke risk appeared to be mitigated by treatment with certain classes of diabetes drugs.

AHA issues policy statement on reducing lower-extremity amputations

Amputations among U.S. patients with diabetes decreased between 2000 and 2009 but increased by 50% from 2009 to 2015, leading the American Heart Association (AHA) to call for better identification and treatment of peripheral artery disease and propose policy solutions.

MKSAP Quiz: Infected wound and diabetes

This month's quiz asks readers to evaluate a patient with type 2 diabetes who was hospitalized for an arm wound and has developed new pain in the middle of his back and difficulty urinating.

Spotlight on COVID-19 and diabetes medications

Several recent studies have found evidence that outcomes from COVID-19 differ by the diabetes medications patients were taking before they got sick, including metformin being associated with better outcomes, but confounding by indication is likely, researchers noted.

Watch out for NAFLD, and help patients get more exercise

The April ACP Internist looked at two issues related to diabetes— the high prevalence of nonalcoholic fatty liver disease (NAFLD) and how some internists have succeeded in getting their patients to exercise more.